Aeternum Health (AETN) Cash & Equivalents (2010 - 2026)

Aeternum Health has disclosed Cash & Equivalents across 17 years of filings, most recently posting $19156.0 for Q1 2026.

• In Q1 2026, Cash & Equivalents changed N/A year-over-year to $19156.0; the TTM figure through Mar 2026 stood at $19156.0 (changed N/A YoY), while the FY2024 annual figure was $18332.0, down 93.58% from the prior year.
• Cash & Equivalents declined to $19156.0 in Q1 2026, from $53881.0 in the prior quarter.
• Over the last five years, Cash & Equivalents for AETN reached as high as $517898.0 in Q2 2023 and fell as low as $18332.0 in Q4 2024.
• The 5-year median for Cash & Equivalents is $161777.0 (2022), against an average of $181343.7.
• Annual changes were most pronounced in 2022 — Cash & Equivalents surged 1045580.95% — and 2023, when it sank 64.11%.
• A 5-year view of Cash & Equivalents shows it stood at $146466.0 in 2022, then jumped by 89.87% to $278097.0 in 2023, then sank by 93.41% to $18332.0 in 2024, then soared by 193.92% to $53881.0 in 2025, then slumped by 64.45% to $19156.0 in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $19156.0, $53881.0, and $18332.0 for Q1 2026, Q3 2025, and Q4 2024 respectively.